Literature DB >> 2025477

Brain and spinal cord metabolic activity during propofol anaesthesia.

M Cavazzuti1, C A Porro, A Barbieri, A Galetti.   

Abstract

We have investigated the effects of propofol anaesthesia on the metabolic activity pattern of 35 regions of the rat brain and cervical spinal cord using the 14C-2-deoxyglucose technique. Anaesthesia was produced by an i.v. bolus of the commercial preparation of the drug (8 mg kg-1) and maintained with successive bolus administrations of 6 mg kg-1. Functional activity values (expressed as rates of local utilization of glucose) were reduced in 31 grey matter and two white matter structures in a propofol group relative both to saline-injected and vehicle-injected (aqueous emulsion containing 10% soya bean oil, 1.2% egg phosphatide and 2.25% glycerol) controls. Values from the two control groups did not differ significantly. Propofol-induced depression of metabolic activity was present in central nervous system regions belonging to sensory (auditory, visual and somatosensory), motor and limbic systems, including spinal cord grey matter. Mean percentage decreases ranged from 40% (vestibular nuclei) to 76% (cingulate cortex). Although these values may be slightly overestimated because of the modest increase in PaCo2 in the anaesthetized group, propofol appeared to elicit generalized reduction of central nervous system functional activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2025477     DOI: 10.1093/bja/66.4.490

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  15 in total

1.  Microdialysate concentration changes do not provide sufficient information to evaluate metabolic effects of lactate supplementation in brain-injured patients.

Authors:  Gerald A Dienel; Douglas L Rothman; Carl-Henrik Nordström
Journal:  J Cereb Blood Flow Metab       Date:  2016-09-07       Impact factor: 6.200

2.  Multiphasic modification of intrinsic functional connectivity of the rat brain during increasing levels of propofol.

Authors:  Xiping Liu; Siveshigan Pillay; Rupeng Li; Jeannette A Vizuete; Kimberly R Pechman; Kathleen M Schmainda; Anthony G Hudetz
Journal:  Neuroimage       Date:  2013-07-10       Impact factor: 6.556

3.  Drug metabolism within the brain changes drug response: selective manipulation of brain CYP2B alters propofol effects.

Authors:  Jibran Y Khokhar; Rachel F Tyndale
Journal:  Neuropsychopharmacology       Date:  2010-11-24       Impact factor: 7.853

4.  Brain mechanisms of propofol-induced loss of consciousness in humans: a positron emission tomographic study.

Authors:  P Fiset; T Paus; T Daloze; G Plourde; P Meuret; V Bonhomme; N Hajj-Ali; S B Backman; A C Evans
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

5.  Propofol in the management of refractory status epilepticus: a case report.

Authors:  A Borgeat; O H Wilder-Smith; P Jallon; P M Suter
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

Review 6.  Propofol in patients with cardiac disease.

Authors:  N R Searle; P Sahab
Journal:  Can J Anaesth       Date:  1993-08       Impact factor: 5.063

Review 7.  Propofol. An update of its use in anaesthesia and conscious sedation.

Authors:  H M Bryson; B R Fulton; D Faulds
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

8.  Propofol analgesia in central pain: preliminary clinical observations.

Authors:  S Canavero; V Bonicalzi; C A Pagni; G Castellano; R Merante; S Gentile; G B Bradac; M Bergui; P Benna; S Vighetti
Journal:  J Neurol       Date:  1995-09       Impact factor: 4.849

9.  Adjuvant propofol enables better control of nausea and emesis secondary to chemotherapy for breast cancer.

Authors:  A Borgeat; O Wilder-Smith; M Forni; P M Suter
Journal:  Can J Anaesth       Date:  1994-11       Impact factor: 5.063

10.  Prolonged myoclonus and meningism following propofol.

Authors:  N J Hughes; J B Lyons
Journal:  Can J Anaesth       Date:  1995-08       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.